ArticleApplied health economics and health policy2022

Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway: A Decision Tree Approach.

Bettina Wulff Risør et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.